These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis]. Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852 [TBL] [Abstract][Full Text] [Related]
4. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068 [TBL] [Abstract][Full Text] [Related]
5. Changes in auditory P3 event-related potentials in uremic patients undergoing haemodialysis. Gallai V; Alberti A; Buoncristiani U; Firenze C; Mazzotta G Electromyogr Clin Neurophysiol; 1994; 34(7):397-402. PubMed ID: 7859667 [TBL] [Abstract][Full Text] [Related]
6. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702 [TBL] [Abstract][Full Text] [Related]
7. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B Nephron; 1996; 72(2):135-44. PubMed ID: 8684516 [TBL] [Abstract][Full Text] [Related]
8. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Kobayashi S; Maejima S; Ikeda T; Nagase M Nephrol Dial Transplant; 2000 Jan; 15(1):65-70. PubMed ID: 10607769 [TBL] [Abstract][Full Text] [Related]
9. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease. Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871 [TBL] [Abstract][Full Text] [Related]
10. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Alhamdani MS Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350 [TBL] [Abstract][Full Text] [Related]
11. Medical problems in dialysis patients awaiting renal transplantation. Lee GS Ann Acad Med Singap; 1991 Jul; 20(4):519-23. PubMed ID: 1799267 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Yang F; Lau T; Luo N Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of serum sialic acid concentration in chronic renal failure children on continuous ambulatory peritoneal dialysis and hemodialysis]. Szprynger K; Szczepańska M; Mazur B; Dyduch A; Zwolińska D; Morawiec-Knysak A; Makulska I Pol Merkur Lekarski; 2000 Jul; 8(49):459-61. PubMed ID: 11070713 [TBL] [Abstract][Full Text] [Related]
14. Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients. Schwabe RF; Engelmann H; Hess S; Fricke H Clin Exp Immunol; 1999 Jul; 117(1):153-8. PubMed ID: 10403929 [TBL] [Abstract][Full Text] [Related]
15. Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients. McKenna RM; Macdonald C; Bernstein KN; Rush DN Nephron; 1994; 67(2):190-6. PubMed ID: 8072608 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro production of tumour necrosis factor by monocytes in dialysis patients. Ryan J; Beynon H; Rees AJ; Cassidy MJ Blood Purif; 1991; 9(3):142-7. PubMed ID: 1801856 [TBL] [Abstract][Full Text] [Related]
17. Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients. Hörkkö S; Huttunen K; Läärä E; Kervinen K; Kesäniemi YA Ann Med; 1994 Aug; 26(4):271-82. PubMed ID: 7946245 [TBL] [Abstract][Full Text] [Related]